Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Biochemical and Biophysical Research Communications|May 29, 1986
In vivo stimulation by antitumor drugs of the topoisomerase II induced cleavage sites in c-myc protooncogeneJ F Riou, E Multon, M J Vilarem, et al.
British Journal of Cancer|September 1, 1990
Analysis of the c-Ha-ras-1 gene for deletion, mutation, amplification and expression in lymph node metastases of human head and neck carcinomasZ M Sheng, M Barrois, J Klijanienko, et al.
Bulletin Du Cancer|January 1, 1990
[c-myc and c-Ha-ras proto-oncogenes in cervical cancer: prognostic value]G Riou, Z M Sheng, D Zhou, et al.
Molecular Carcinogenesis|March 1, 1995
The p53 and mdm-2 genes in human testicular germ-cell tumorsG Riou, M Barrois, S Prost, et al.
Human Pathology|December 1, 1995
p53 mediated tumor cell response to chemotherapeutic DNA damage: a preliminary study in matched pairs of breast cancer biopsiesU M Moll, A G Ostermeyer, J C Ahomadegbe, et al.
Lancet (London, England)|April 4, 1987
C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervixG Riou, M Barrois, M G Lê, et al.
Cancer Research|September 15, 1989
Expression of a human multidrug resistance gene in ovarian carcinomasJ Bourhis, L J Goldstein, G Riou, et al.
Biochemical Pharmacology|June 15, 1991
Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferaseD Lefevre, J F Riou, J C Ahomadegbe, et al.
International Journal of Oncology|May 17, 2011
Expression of the human fetal bac h19 gene in invasive cancersS Doucrasy, J Coll, M Barrois, et al.
Oncogene|January 18, 1996
High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19S Douc-Rasy, M Barrois, S Fogel, et al.
Pageof 8